These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17409457)

  • 21. Discovery and identification of anti-U1-A snRNP antibody in lung cancer.
    Zhang L; Liu J; Zhang H; Wu S; Huang L; He D; Xiao X
    Sci China C Life Sci; 2005 Dec; 48(6):641-7. PubMed ID: 16483144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum.
    Kilic A; Schuchert MJ; Luketich JD; Landreneau RJ; Lokshin AE; Bigbee WL; El-Hefnawy T
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):199-204. PubMed ID: 18603076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer.
    Farlow EC; Patel K; Basu S; Lee BS; Kim AW; Coon JS; Faber LP; Bonomi P; Liptay MJ; Borgia JA
    Clin Cancer Res; 2010 Jul; 16(13):3452-62. PubMed ID: 20570928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies as potential biomarkers for breast cancer.
    Zhong L; Ge K; Zu JC; Zhao LH; Shen WK; Wang JF; Zhang XG; Gao X; Hu W; Yen Y; Kernstine KH
    Breast Cancer Res; 2008; 10(3):R40. PubMed ID: 18460216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers.
    Patel K; Farlow EC; Kim AW; Lee BS; Basu S; Coon JS; DeCresce D; Thimothy L; Walters KA; Fhied C; Chang C; Chen SH; Faber LP; Bonomi P; Liptay MJ; Borgia JA
    Int J Cancer; 2011 Jul; 129(1):133-42. PubMed ID: 20824709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma.
    Ali Eldib AM; Ono T; Shimono M; Kaneko M; Nakagawa K; Tanaka R; Noguchi Y; Nakayama E
    Int J Cancer; 2004 Feb; 108(4):558-63. PubMed ID: 14696120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of antibody biomarkers using protein microarrays of tumor antigens cloned in high throughput.
    Chatterjee M; Wojciechowski J; Tainsky MA
    Methods Mol Biol; 2009; 520():21-38. PubMed ID: 19381945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preparation and characterization of human phage display antibody against peroxiredoxin I of lung adenocarcinoma].
    Luo Y; Pang H; Li SJ; Cao H; Li SL; Fan CB; Wang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):30-4. PubMed ID: 20117978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
    Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
    Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibody profiles as biomarkers of breast cancer.
    Tabernero MD; Lv LL; Anderson KS
    Cancer Biomark; 2010; 6(5-6):247-56. PubMed ID: 20938085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative autoantibody profiling before and after appearance of malignance: identification of anti-cathepsin D autoantibody as a promising diagnostic marker for lung cancer.
    Luo X; Lu F; Wang HL; Wang N; Li WH; Guo N; Wang HX; Xia Q
    Biochem Biophys Res Commun; 2012 Apr; 420(4):704-9. PubMed ID: 22310721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice.
    Mizukami M; Hanagiri T; Yasuda M; Kuroda K; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; So T; Takenoyama M; Sugio K; Yasumoto K
    Cancer Res; 2007 Sep; 67(17):8351-7. PubMed ID: 17804751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of human lung cancer antigens by serological screening with autologous antibodies.
    Hanafusa T; Mohamed AE; Kitaoka K; Ohue Y; Nakayama E; Ono T
    Cancer Lett; 2011 Feb; 301(1):57-62. PubMed ID: 21094583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies in prostate cancer.
    Kida Y
    N Engl J Med; 2005 Dec; 353(26):2815-7; author reply 2815-7. PubMed ID: 16382546
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoantibodies as potential biomarkers for nasopharyngeal carcinoma.
    Tong YQ; Zhang ZJ; Liu B; Huang J; Liu H; Liu Y; Guo FJ; Zhou GH; Xie PL; Li YH; Zuo CH; Hu JY; Li GC
    Proteomics; 2008 Aug; 8(15):3185-93. PubMed ID: 18654982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
    Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
    Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiling tumor-associated autoantibodies for the detection of colon cancer.
    Ran Y; Hu H; Zhou Z; Yu L; Sun L; Pan J; Liu J; Yang Z
    Clin Cancer Res; 2008 May; 14(9):2696-700. PubMed ID: 18451234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays.
    Babel I; Barderas R; Diaz-Uriarte R; Moreno V; Suarez A; Fernandez-Aceñero MJ; Salazar R; Capellá G; Casal JI
    Mol Cell Proteomics; 2011 Mar; 10(3):M110.001784. PubMed ID: 21228115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.
    Looi K; Megliorino R; Shi FD; Peng XX; Chen Y; Zhang JY
    Oncol Rep; 2006 Nov; 16(5):1105-10. PubMed ID: 17016600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
    Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
    Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.